Electrocardiographic QTc changes due to moxifloxacin infusion.
about
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Impact of electrocardiographic data quality on moxifloxacin response in thorough QT/QTc studies.Facts, fancies and follies of drug-induced QT/QTc interval shortening.Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjectsEffect of trabectedin on the QT interval in patients with advanced solid tumor malignanciesPharmacogenetics of Drug-Induced QT Interval Prolongation: An UpdateUpdate on the cardiac safety of moxifloxacin.ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies.Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongation.Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.Cardiovascular and metabolic safety profiles of the fluoroquinolones.Categorization and theoretical comparison of quantitative methods for assessing QT/RR hysteresis.Slow QT interval adaptation to heart rate changes in normal ambulatory subjects.Concentration-QT analysis of the randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects.
P2860
Q27006580-106339A5-8263-43D5-A145-18CCB6ED75A9Q30760769-9C8BA284-97F4-442F-909B-2706B567C039Q33661036-62ECBB42-B0BB-422F-A021-BB4BA09C0ACEQ34347165-9C6D73FE-8725-4A6C-BF2B-CA74701A6ADFQ35693620-7B9AF18C-D113-4039-99EC-03F0D91839DCQ36084069-86EA20B9-288E-4CA0-979B-CAEE060A1953Q36345861-F151BAE3-3607-4CEF-A9D0-1A81F1DCB4A1Q36729914-8C1DAD71-1B48-4760-B1B6-18EA3C59242CQ37579944-7B45811F-6602-45A1-9E6E-284B3CF3132AQ37914886-8E4D28DF-3074-40E5-AD69-0C39C5C44437Q37940543-E5CC7CFE-20E5-4404-9DEA-697B4F051422Q39311065-DB2A0794-9437-4E0D-8D48-CCE35262F142Q47253777-A0DA0770-63E2-4F36-BDCB-D07E9B0DC606Q48701234-7606C60E-6A91-4C07-A0CB-960ED33EB6FEQ49792134-5BAA75E9-A8F4-49C8-8714-C4DD55855929Q51568037-F1139934-90B2-4A78-90F3-53D66D681F8C
P2860
Electrocardiographic QTc changes due to moxifloxacin infusion.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Electrocardiographic QTc changes due to moxifloxacin infusion.
@en
Electrocardiographic QTc changes due to moxifloxacin infusion.
@nl
type
label
Electrocardiographic QTc changes due to moxifloxacin infusion.
@en
Electrocardiographic QTc changes due to moxifloxacin infusion.
@nl
prefLabel
Electrocardiographic QTc changes due to moxifloxacin infusion.
@en
Electrocardiographic QTc changes due to moxifloxacin infusion.
@nl
P2093
P2860
P356
P1476
Electrocardiographic QTc changes due to moxifloxacin infusion.
@en
P2093
Anna Schmidt
Katerina Hnatkova
Marek Malik
Peter Smetana
P2860
P304
P356
10.1177/0091270008330984
P577
2009-06-01T00:00:00Z